Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry
In this episode of the CardioNerds Cardiovascular Prevention Series, we discuss the clinical implementation of glucagon-like peptide-1 (GLP-1) receptor agonists
Effect of Butyrate and Inulin Supplementation on Glycemic Status, Lipid Profile and Glucagon-Like Peptide 1 Level in Patients With Type 2 Diabetes: A Randomized Double-Blind, Placebo-Controlled Trial
The playbook doesn't require a brand overhaul it requires reading your own data and making targeted adjustments
In older adults, oxybutynin is associated with increased risk of central nervous system adverse effects, including confusion and cognitive impairment, warranting caution in patients with dementia or other geriatric vulnerabilities
Genetic markers in GLP1R, GIPR, FTO, and MC4R can reveal how your body is likely to respond to GLP-1 signaling and metabolic shifts